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Intermediary Metabolism of the Lung
by Aron B. Fisher*
The lung is a metabolically active organ that is engaged in secretion, clearance and other maintenance
functions that require reducing potential, energy and substrates for biosynthesis. These metabolic
requirements are met in part through uptake and catabolism of glucose which represents the major fuel
utilized by lung tissues. Gluconeogenesis does not occur, and glycogen stores are limited so that the lung
depends on the circulation for its glucose requirement. Other substrates can be metabolized by lung and
contribute to the metabolic pool although their role has been less thoroughly studied. Glucose is
catabolized in the lung by cytoplasmic and mitochondrial pathways that are responsive to regulatory
mechanisms as in other tissues. Activity of the pentose cycle pathway of glucose catabolism is relatively
high and generates the NADPH required for biosynthesis oflipid, detoxification reactions, and protection
against oxidant stress. The ATP content of the lung is maintained by oxidative metabolism at levels
comparable to othermetabolically active organs. Alterations in lung intermediary metabolism may depress
amine clearance, alter lung permeability, and influence the lung response to oxidant stress.
Although once considered a passive conduit for ex-
change of gases, it is now recognized that lung tissue
carries out important metabolic activity (1-4). This
realization has led to a flurry ofinvestigation which has
greatlyincreased ourknowledgeofintermediarymetabo-
lism of the lung. Nevertheless, much remains to be
accomplished before we gain complete understanding of
the relationships between cellular metabolic activity
and overall lung function including the mechanisms by
which intermediary metabolism is altered in the pres-
ence of disease. With the development of effective
methods for isolation of individual cell types (5-10), it
seems likely that major progress in the near future will
be toward understanding intermediary metabolism as a
function of lung cell type. The present paper will not
describe this aspect oflung metabolism but will review
the integrated metabolic activity of the lung. The
information that will be presented has been obtained
primarily with the isolated perfused adult rat lung
preparation.
GlucoseUtilizationandIntermediary
Metabolism: Overview
The overall role of intermediary metabolism in cell
homeostasis is primarily to generate the requisite
energy for cellular functions and to provide the small
molecular weight substrates for biosynthetic processes.
In lung cells as in most tissues, a variety of substrates
derived from protein, lipid and carbohydrate precursors
can enter the cellular pool ofintermediary metabolites.
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Thus, lung tissue can oxidize to a variable degree
glucose, fatty acids, amino acids, lactate, and glycerol
(11-13). However, the rate of glucose oxidation is
greatest and is not appreciably influenced by added
palmitate (14), suggesting that glucose serves as the
major oxidizable substrate under normal physiological
conditions. Therefore, this paper emphasizes glucose
metabolism by the lung, including pathways for the
utilization ofglucose and the role ofglucose metabolism
ingeneration ofreducingequivalents and energy stores.
Glucose Transport
The initial event in glucose utilization by tissues is its
transcellular transport which in most cells occurs by
carrier-mediated facilitated diffusion (15). However,
some epithelia such as renal cortex and intestine
accumulate glucose (and other hexoses) against a con-
centration gradient by an active transport process
(16,17). Mechanisms of glucose transport can be most
easily studied through use of nonmetabolizable glucose
analogs so that the transport step can be separated
from subsequent metabolic transformations. Recently
this approach has been used to evaluate mechanisms of
hexose uptake in the perfused lung preparation. 2-
Deoxyglucose and 3-0-methyl glucose were taken up by
facilitated diffusion and did not accumulate against
concentration gradients (18,19). On the other hand,
a-methylglucoside did accumulate against a concentra-
tion gradient by a sodium-dependent process, suggest-
ing active transport (19). Therefore, there is apparently
more than one transport system for hexoses in the lung
and both facilitated diffusion and active transport may
occur. Glucose itself probably utilizes both systems
since this substrate competes for uptake with non-A. B. FISHER
metabolizable analogs (19). It is possible that multiple
uptake mechanisms reflect the contribution of more
than one cell type. Although the cell types involved in
each of these uptake processes has not yet been
determined, analogy with other tissues suggests that
epithelium is a most likely site for active transport.
Glucose Utilization
The most direct way to measure glucose utilization is
by the rate of disappearance of glucose from the
medium during lung perfusion. However, this technique
is difficult to apply to lungs because of the normally
large perfusate flow rate relative to metabolizing tissue
mass. As an alternative method, glycolytic rate can be
measured from the rate of generation of 3H20 from
glucose specifically labeled with tritium (20). In the case
of glucose labeled in the 5-position, tritium is liberated
during glycolysis at the triose phosphate isomerase and
enolase catalyzed steps (Fig. 1). The advantage of this
method is that the appearance of the radiolabeled
metabolic product (H20) is easierto measure than is the
disappearance of the substrate (glucose).
Utilization ofglucose bythelung asindicated by3H20
production varies with perfusate glucose concentration
(21). The calculated glucose utilization at infinite sub-
strate concentration is 72 ,umole/hr/g dry weight or
approximately 15 ,umole/hr/g wet weight (21). Glucose
utilization is one-halfmaximal at a perfusate concentra-
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FIGURE 1. Scheme for the glycolytic pathway indicating the sites
of 3H20 production from glucose labeled with tritium in the
5-position. Also indicated are the sites of entry of carbon from
glycogen and amino acids into the glycolytic pathway.
tion of 3.4 mM (21) to 4.7 mM (22). With perfusate
glucose concentration of 5.6 mM (the approximate
resting physiologic concentration), glucose utilization is
40 to 50 ,umole/hr/g dry weight (20,21). This rate of
glucose utilization is similar on a weight basis to that of
other metabolically active organs such as the brain and
heart (3).
Products of Glucose Metabolism
The major pathways for catabolism ofglucose include
the glycolytic (Embden-Meyerhof) and pentose phos-
phate pathways. These reactions produce lactate and
CO2 as major end products and generate glycerol-
3-phosphate, pyruvate, and ribose which can be utilized
as intermediates for synthesis of lipids and nucleic
acids, transamination to amino acids, and oxidation via
the Krebs cycle. The catabolism of glucose also gener-
atesreduced pyridine nucleotides (NADPH and NADH),
reducing potential which is essential in the extra-
mitochondrial compartment for reductive biosynthesis
and detoxification reactions and, after transfer into the
mitochondria, can be utilized for energy generation via
the electron transport chain. Finally, the catabolism of
glucose results in synthesis of high energy compounds
(ATP). The net ATP gain from glycolysis is relatively
small butmaybe physiologically important. This section
discusses the fate of glucose carbons; subsequent sec-
tions will describe the role of glucose in generation of
reducing equivalents and ATP
The approximate fate of glucose metabolized by the
perfused lung, traced through the use ofglucose labeled
with 14C, is summarized in Figure 2. The major fraction
(40-50%) of glucose carbons is metabolized to the
three-carbon compounds lactate and pyruvate (23). The
distribution between lactate and pyruvate production
varies with the redox state ofthe cell, but undercontrol
conditions, lactate production is approximately 10-fold
greater (23). These three-carbon products of glycolysis
readily appear in the lung perfusate. The flux to lactate
as a percent of glucose utilized in the aerobic perfused
lung is relatively high compared with other organs. For
example, lactate production by the perfused rat heart
(in the presence of insulin) is only 20 to 25% of glucose
utilization (24). One possibility to account for the high
rate of lactate production is that the relatively large
pulmonary perfusion rate might allow relatively greater
rates of diffusion of lactate and pyruvate from the cells
compared with other organs. As another possibility,
some compartments of the lung may be relatively
deficient in mitochondrial enzymes with consequent
greater dependence on glycolytic pathways. (Ultra-
structural examination suggests that membranous epi-
thelium could be such a compartment.) The high lactate
production in the normal lung is not due to cellular
hypoxiasincechangesinalveolarP02donotsignificantly
affect lung lactate production until very low levels of
P02 are attained (25,26). Exogenous lactate added to
the perfusate can enter the cellular metabolic pool andINTERMEDIARY METABOLISM OF THE LUNG
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FIGURE 2. Recovery of carbon atoms derived from glucose and
products of metabolism during perfusion of the isolated rat lung
with 5.5 mM [U-14C] glucose in Krebs bicarbonate solution, pH
7.4, containing3% bovine serumalbumin. Thedata arerepresented
as percent of total recovery (20,23,39).
(after conversion to pyruvate) can be further metabo-
lized via pathways for utilization of three-carbon frag-
ments (13,22,27).
Oxidation to CO2 represents the second major fate of
glucose carbons (Fig. 2). The reactions that generate
CO2 include the cytoplasmic pentose shunt pathway of
metabolism and mitochondrial reactions catalyzed by
pyruvate dehydrogenase and enzymes of the tricarbox-
ylic acid (Krebs) cycle. Of the total CO2 production by
the perfused lung, approximately one-fourth is gener-
ated from the pentose shunt, one-fourth from the
pyruvate dehydrogenase reaction, and one-half by the
tricarboxylic acid cycle (20).
The other major fate of glucose carbons is their
utilization for biosynthesis of more complex molecules
including polysaccharides, proteins, and lipids. Incorpo-
ration into polysaccharides probably reflects predomi-
nantly synthesis ofglycogen. The glycogen stores in the
lung (1-3 mg/g wet weight) (21,28,29) are markedly less
than those ofthe liver from a well-fed animal, but in the
approximate range of other organs'that do not specific-
ally store glycogen. The incorporation of glucose car-
bons into glycogen (23) indicates a turnover of approxi-
mately 3% oftissue glycogen/hr. The factors responsible
for mobilization of glycogen in the lung cells have not
been described but the size of this pool appears to be
stable during short-term glucose deprivation (21) or
during 3 days of fasting (22).
Glucose carbons are also readily incorporated into
protein and nucleoproteins (23,30). A major site of
entryintothe amino acid poolis likely through transami-
nation of pyruvate to produce alanine. Other potential
points of interchange of carbon atoms include Krebs
cycle intermediates and ribose generated in the pentose
cycle. In common with most other tissues, the protein
components of the lung are in constant flux with
degradation and resynthesis proceeding at variable
rates depending on the protein (31). Thus, not only are
three-carbonintermediatesfromglycolysisreadilyincor-
porated into protein, but alanine and possibly other
amino acids from protein degradation enter the meta-
bolic pool where they can appear in the lung perfusion
fluid as lactate (22). The rate oflactate generation from
these nonglucose sources is relatively independent of
lactate production from glucose and may account for
25% or more of total lactate production (21,32).
Complex lipids are also synthesized by lungs from
glucose carbons. Glucose carbons appear in both the
fatty acyl moiety, presumably synthesized via acetyl
CoA, and the glyceride-glycerol moiety arising from
glycerol phosphate (or dihydroxyacetone phosphate)
(33). Small quantities of glucose carbons may also be
incorporated into ethanolamine or other phospholipid
side chains. In our studies with the perfused lung,
incorporation of glucose carbon into the fatty acyl
moiety was about 60% of total incorporation (34)
although other investigators have suggested that this
component may account for only 25 to 40% (28,35). The
precise distribution of incorporation between the lipid
compartments may vary with the availability of fatty
acids in the perfusate or nutritional status and age of
the animals (11,36,37). Thus, adult animals, starvation
or the presence of palmitate in the perfusate resulted
in increased relative glucose incorporation into the
glyceride-glycerol as opposed to fatty acyl moiety.
Gluconeogenesis
Although glucose utilization by lung has been exten-
sively studied, the possibility of gluconeogenesis from
two- or three-carbon precursors has not received the
same attention. The activity of phosphoenolpyruvate
carboxykinase, one of the rate-limiting enzymes in
gluconeogenesis, is verylowinlungtissue (38), suggest-
ing that the gluconeogenic pathway is not of major
importance. Therefore, circulating glucose is the proba-
ble major source of lung intracellular carbohydrate.
Control of Glycolytic Flux
Metabolic control of the glycolytic pathway can be
analyzed from the standpoint of agents that exert
regulation over the long or over the short term.
Long-term regulation occurs chiefly through the effect
of hormones and other mediators on the enzymes
involved in glucose uptake and metabolism. Short-term
control occurs by regulation ofenzyme activity through
changes in concentration of important reactants and
modifiers. Two important glycolytic regulators of the
second class are the cellular ATP concentration (or
perhaps ATP/ADP or the energy charge ofthe cell) and
thecellularNAD+ concentration(ortheNAD+/NADHor
redox state ofthe cell). In other tissues, glycolytic flux
increases in response to ATP depletion (assuming suffi-
cientATPforglucose phosphorylation) and decreases as
NAD+ is depleted. Operation ofthese short-term regu-
151A. B. FISHER
lators has been evaluated in the perfused lung by using
metabolicinhibitorswithdifferentmechanismsofaction.
To study the role of ATP, lungs were perfused with
dinitrophenol (DNP), an uncoupler of oxidative phos-
phorylation, or ventilated with carbon monoxide (CO),
which inhibits oxidative phosphorylation through com-
petition with 02 for cytochrome oxidase. DNP sig-
nificantly decreased the ATP and ATP/ADP (39), while
CO depressed cellular energy state to an even greater
degree (23). Both of these metabolic inhibitors stimu-
lated the rate ofglycolysis, indicating responsiveness of
the system to ATP depletion. The effect of CO is
analogous to the classic Pasteur effect, i.e., stimulation
of glycolysis secondary to 02 lack. Thus, lung tissue
demonstrates a brisk Pasteur effect with an increase in
glycolytic activity of 2.5-fold in response to complete
inhibition of mitochondrial oxidations (23).
It should be noted that glycolysis was stimulated by
CO (Thble 1), despite amarked reduction ofcytoplasmic
pyridine nucleotides (that is, elevated NADH/NAD + as
reflected by increased lactate/pyruvate). We have re-
cently shown that perfusion with pyruvate to decrease
the redox ratio leads to a further stimulation ofglycoly-
sis in the presence of CO (40). The effect of redox
state on glycolysis was further evaluated by perfusion
of lungs with phenazine methosulfate (PMS), which
can directly oxidize the reduced cytoplasmic pyridine
nucleotides. PMS did not affect lung energy status
but significantly decreased lactate to pyruvate ratio
(indicating shift of cytoplasmic redox state toward
oxidation) (Table 1). PMS also stimulated the glycolytic
pathway of glucose utilization (39). Thus, glycolysis
responds to redox state independently of changes in
energy status.
The provision of mitochondrial (Krebs cycle) sub-
strate can also have a regulatory effect on glycolysis.
Recent observations from our laboratory indicate that
glycolysis is inhibited in the presence of 1-2 mM lactate
(40). Pyruvate is also inhibitory. This effect is not due
to alteration of redox ratio but most likely reflects
increased citrate synthesis by the mitochondria with
subsequent inhibition ofcytosolic phosphofructokinase.
A similar inhibition by lactate on lung metabolism has
been observed for the oxidation ofglucose to CO2 (13).
Table 1. Effect of metabolic inhibitors on glucose utilization by
the perfused rat lung.a
Glucose utilization, Glucose conversion,
,umole/hr/g dry wt. ,umole/hr/g dry wt. Lact/
Total Via E-M ToLact + Pyr To CO2 Pyr
Control 44.4 39.1 16.5 8.8 10
COb 63.3 62.7 64.5 1.9 53
DNP 79.9 75.7 32.5 17.9 13
PMS 64.3 53.9 21.9 19.1 4
a Perfusate contained 5.6 mMglucose plus insulin; DNP = 0.08mM
dinitrophenol; PMS = 8mMphenazinemethosulfate; E-M = Embden-
Meyerhof pathway (calculated as total minus pentose pathway).
b Lungs ventilated with 0.95 ATA CO; 0.05 ATA CO2.
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FIGURE 3. ATP content and ATP/ADP ratio in the isolated per-
fused rat lung: under control conditions, during ventilation with
CO, perfusion with dinitrophenol, or perfusion with phenazine
methosulfate (23,39).
The results with metabolic inhibitors (see Fig. 3 and
Table 1) and substrates indicate that regulatory mecha-
nisms for glycolysis in lung cells are qualitatively similar
to those in other tissues.
The evidence for hormonal regulation oflung glycoly-
sis is less clear. Most studies in this area have been
directed toward the role of insulin. Insulin-specific
receptors have been demonstrated in crude membrane
preparations from normal lungs (41) and insulin may
modulate lung lipid synthesis (35,42) and proteolysis
(43). On the other hand, possible effects ofadded insulin
on glycolytic activity have been difficult to confirm in
the control perfused lung, perhaps related to the
persistence of endogenous insulin already bound to
receptors. Lactate production and glucose utilization
were stimulated in the presence ofinsulin (21,44) but in
one study (21) the effect was observed only at a low
glucose concentrations. Isolated perfused lungs showed
increased uptake of 2-deoxy-D-glucose in the presence
of insulin (18). Furthermore, lungs from diabetic rats
had decreased glucose oxidation and decreased uptake
of2-deoxy-D-glucose (18,41). Thus, the studies provide
evidence that insulin has a role in regulation of lung
glucose utilization, although the currently available
data suggest that the effect is not major. Possible
regulatory roles ofthyroid, adrenal and other hormones
that may be predicted to affect glucose utilization have
not been adequately evaluated in the lung.
GenerationofReducing Equivalents
In addition to generating carbon substrates for fur-
ther oxidation or for biosynthetic reactions, the catabo-
lism ofglucose generates reducing equivalents which in
turn are used for reductive biosynthesis, detoxification
reactions, and generation of ATP via the mitochondrial
electron transport chain. Cytoplasmic reducing equiva-
lents are generated as NADH during glycolysis and
NADPH from the reactions of the pentose shunt
pathway. Mitochondrial reducing equivalents, which are
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generated as NADH and reduced flavins from reactions
including pyruvate dehydrogenase and Krebs cycle, are
linked directly to the mitochondrial electron transport
chain.
Generation of NADPH
NADPH is the major biological reductant for a wide
variety of biosynthetic and detoxification reactions.
Reactions that generate NADPH in the cytoplasm
include the pentose pathway (glucose-6-phosphate dehy-
drogenase and6-phosphogluconatedehydrogenase), con-
version of malate to pyruvate by malic enzyme, and
conversion of isocitrate to a-ketoglutarate by isocitric
dehydrogenase; since mitochondria also have a NADP+-
linked isocitric dehydrogenase, this provides a mecha-
nism by which NADPH generated in the mitochondria
can be "shuttled" into the cytoplasm. All of these
NADPH-generating enzymes are present in the lung
although activity of malic enzyme is low and the
quantitative contribution ofthe isocitric dehydrogenase
reaction has not been evaluated (28,45). Therefore, the
major source of NADPH in the lung cytoplasm is
assumed to be the pentose pathway.
The role of the pentose pathway can be evaluated by
comparing C02 production from glucoses labeled in the
1- and inthe 6-position. Ifglucoseutilizationismeasured
simultaneously, pentose shunt activity can be calculated
from the Katz and Wood model (46). In the perfused rat
lung, the ratio of C02 production from C-1 and C-6
labels was approximately 4, and calculated activity of
the pentose cycle was approximately 12% of total
glucose utilization (20). C02 produced by the pentose
cycle was 16 pLmole/hr/g dry weight, which represents
approximately 25% oftotal C02 production (20). Since 2
mole NADPH are produced per mole of C02, mean
NADPH production fromthe pentose cycle wasapproxi-
mately 32 ,umole/hr/g dry weight. PMS, an agent which
interacts with cytoplasmic pyridine nucleotides as dis-
cussed above, stimulated pentose cycle activity about
2-fold (Table 2). CO ventilation markedly depressed
pentose cycle activity, probably by inhibiting NADPH
utilization, while DNP had no effect on NADPH
generation. These results provide evidence that this
pathway is regulated by the rate ofNADPH utilization.
An interesting observation was that the pentose path-
way estimated from specific yields of C-1 and C-6
glucose in lipids was significantly higher than estimates
based on C02 (20). This result could be interpreted as a
manifestation ofcellular heterogeneity ofdistribution of
the pentose cycle, possibly reflecting the increased
utilization of NADPH by cells actively engaged in lipid
synthesis.
Recent experiments have suggested that in addition
to the pentose cycle, mitochondrial generation of
NADPH may be significant in some situations. Using
the perfused lung, we evaluated the conversion of
p-nitroanisole to p-nitrophenol, a mixed function oxida-
tion requiring NADPH. The reaction required the
Table 2. Pentose pathway of the isolated perfused rat lung.a
% of NADPH generation,
glucose utilization ,umole/hr/g dry wt.
Control 11.9 32
CO 1.0 4
DNP 5.2 30
PMS 16.1 66
a Conditions as in Table 1.
presence ofglucose for maximal rate, but mitochondrial
substrates (palmitate, pyruvate) were equally effective
(47). Furthermore, mitochondrialinhibitorssignificantly
decreased the rate of the mixed function oxidation
reaction (47). These results suggest that the mitochon-
drial generation of NADPH plays an important role in
the lung, at least for the mixed function oxidation
reaction. Mitochondrial NADPH could be generated by
energy-dependent transhydrogenation from NADH and
shuttled to the cytoplasm. However, the precise nature
of these pathways in the lung remains speculative.
Generation of Cytoplasmic NADH
Glycolysis via the Embden-Meyerhof pathway pro-
duces 2 mole NADH for each mole of glucose metabo-
lized to pyruvate. Reoxidation of the cytoplasmic pyri-
dine nucleotide is essential to permit glycolysis to
proceed. NAD+ can be regenerated through utilization
of NADH in production of lactate from pyruvate or
production ofglycerolphosphate from dihydroxyacetone
phosphate; incorporation of glycerol phosphate into
lipids or efflux of lactate from the lung results in a net
removal of glycolytically generated cytoplasmic reduc-
ing equivalents. The major additional pathway for
removal of cytoplasmic NADH is by oxidation via the
mitochondrial electron transport chain. However, mito-
chondrialmembranes areimpermeable to NADHwhich,
therefore, must be transferred into the mitochondrial
matrix via "hydrogen shuttle" mechanisms.
Data cited above for glucose flux in the isolated
perfused lung indicate that glycolysis produces approxi-
mately 85 ,umole NADH/hr/g dry weight. Of this,
approximately 70 ,umole/hr/g dry weight appear in the
perfusate as lactate but the bulk of the rest (15
,mole/hr/g dry weight) is presumably reoxidized by the
mitochondria after transfer by the mitochondrial "hy-
drogen shuttle"
Activities ofthe shuttle mechanisms for the transfer
ofreducing equivalents from cytoplasm to mitochondria
have not been directly evaluated in the lung. However,
there is evidence that at least two of the shuttles that
have been proposed in other tissues could be functional
in lung tissue. One such proposed shuttle is the
glycerol-3-phosphate pathway in which dihydroxyace-
tone phosphate is reduced to glycerol-3-phosphate in
the cytoplasm and reoxidized in the mitochondria (Fig.
4). Mitochondrial glycerol-3-phosphate dehydrogenase
has been identified in lung mitochondria (48-50) and
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activity of the cytoplasmic enzyme can be presumed
from the significant concentrations of glycerol-3-phos-
phate in lung tissue (26). Another proposed "hydrogen
shuttle" pathway is the malate-aspartate shuttle which
requires influx ofmalate and efflux ofasparate from the
mitochondrial space. Operation of this shuttle requires
transamination in both the cytoplasmic and mitochon-
drial spaces. Evidence that this shuttle is operative in
the lung was provided by the response to infusion of
aminoxyacetic acid, a transaminase inhibitor. This
inhibitor resulted in a marked increase in the lactate to
pyruvate ratio, suggesting reduction of cytoplasmic
pyridine nucleotides due to inhibition of shuttle mecha-
nisms (26).
In summary, mechanisms for transfer of reducing
equivalents between cytoplasmic and mitochondrial
spaces must be present in lung tissue. The enzymatic
components necessary for operation of the glycero-
phosphate shuttle are present in the lung and inhibitor
experiments suggest operation of a malate-aspartate
shuttle. However, quantitative details of the participa-
tion of these or other mechanisms are lacking.
Lung ATP Synthesis and
Energy Stores
Although the breathing process requires a significant
energy expenditure for the organism, the role of the
lungs is essentially passive. Therefore, lung tissue per
se is arelatively modest consumer ofenergy in compari-
son to muscles of respiration or other working tissues
(1). Nevertheless, the lung has energy-dependent func-
tions that for the most part have been relatively poorly
defined. Some of these energy-requiring functions in-
clude lung clearance (phagocytosis and ciliary activity),
bronchial gland secretion, contraction of tracheobron-
chial smooth muscle, surfactant synthesis and secretion,
and maintenance of normal transcellular ion gradients.
Efficient functioning of these energy-dependent sys-
tems requires the maintenance oftissue energy stores.
Lung Energy Stores
The ATP content of the normal perfused lung is
approximately 2 to 2.5 ,umole/g wet weight (23,39,51).
This value is approximately 50% ofthat measured in rat
heart, but is similar to ATP values for rat brain, liver
and kidney (52). Since the intracellular water space of
the perfused lung is approximately 50% of wet weight,
the intracellular ATP concentration is approximately 4
to 5 mM. The ATP/ADP ofthe lung is approximately 8.
The calculated energy charge ([ATP + 0.5 ADP]/[ATP
+ ADP + AMP]) as defined by Atkinson (53) is greater
than 0.9. Thus, the normal lung exists in a highly
energized state similar to other metabolically active
organs (52).
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FIGURE 4. Schematic of the glycerol-3-phosphate (aGP) cycle for
transfer of reducing equivalents between the cytoplasmic and
mitochondrial compartments. Dihydroxyacetone phosphate is re-
duced with NADH by the cytoplasmic glycerol-3-phosphate
dehydrogenase. The product, glycerol-3-phosphate, can enter the
mitochondrion where it is oxidized by the flavin-linked mitochon-
drialglycerol-3-phosphate dehydrogenase. Theproduct, dihydroxy-
acetone phosphate, can then diffuse into the cytoplasm.
ATP Generation
Tissue ATP stores are determined by the balance
between rates of ATP generation and utilization. In
most metabolically active tissues, the bulk of ATP is
generated from mitochondrial oxidation while glycolysis
is only supplemental. The contribution ofglycolytic and
mitochondrial pathways of glucose utilization to ATP
generation in the lung can be estimated from the results
for glucose utilization described above. Production of
lactate or pyruvate generates a equimolar amount of
glycolytic ATP Production of one mole ofpyruvate also
results in the generation of 3 mole mitochondrial ATP
from the oxidation of NADH via the mitochondrial
shuttles. Oxidation ofglucose generates one-third mole
glycolytic ATP and 6 mole mitochondrial ATP/mole of
CO2 produced. Using these relationships for the lung,
generation of ATP is approximately 80% mitochondrial
and 20% glycolytic under control condition (Table 3).
With anoxia produced by CO ventilation, mitochondrial
ATP production is essentially abolished while ATP
generationby cytosolicpathwaysapproximately doubles.
However, the totalrate ofATPgenerationduringanoxia
is reduced by about 70% and is reflected by a marked
decrease in lung ATP content and ATP/ADP (23) (see
Fig. 3). This result indicates that oxidative metabolism
is required in order to maintain the normal energy
status of the lung.
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Table 3. Estimated ATP generation from metabolism of glucose
by the isolated perfused rat lung.a
ATP generation, ,umole/hr/g dry wt.
Cytosolic Mitochondrial Total
Control 62 363 425
COb 124 42 166
a Results represent estimates based on recovery of glucose-carbon
in catabolic products.
b Lungs ventilated with 95% CO, 5% Co2.
Critical Po2 of the Lung Cells
The oxygen tension at which oxidative metabolism is
depressed (critical P02) is of some interest in defining
control of lung metabolism. It should be noted that
diffusion pathways in the lung are extremely short (as
required for proper functioning ofthe organ) compared
with other tissues and that alveolar gas represents a
large reservoir for oxygen at a relatively constant P02.
Therefore, alveolar P02 approximates intracellularP0o,
a relationship that can be strengthened by using the
perfused lung preparation under conditions of no net
gas exchange.
With the isolated lungpreparation, oxidative metabo-
lism as reflected by lactate production, lactate to
pyruvate ratio, and ATP content is not affected until
estimated intracellular Po2 is approximately 1 mm Hg;
complete inhibition of oxidative metabolism requires a
P02 less than 0.04 mm Hg (25,26). The ability of the
lung tissue to sustain oxidative metabolism in the face
of very low P02 likely accounts for previous observa-
tions that the lung is relatively resistant to damage
from hypoxia (54). It should be noted that the "critical"
P02 for the lung roughly corresponds to that measured
for isolated mitochondria from various organs (55). We
postulate that the measured critical P02 of the lung is
probably similar to the critical intracellular P02 for
most other organs. Major differences between lungs
and other organs are that the lung is not dependent
upon vascular perfusion for its oxygen needs and has a
much more favorable balance between oxygen availabil-
ity and oxygen utilization.
Isolated Lung Mitochondria
The mitochondrion is the site of oxidative ATP
generation; inhibition ofthe function ofthis organelle in
situ results in depletion oflung ATP stores as described
above. Evaluation of isolated lung mitochondria is
hampered by cellular heterogeneity ofthe lung and only
a limited amount of baseline information has been
obtained for these organelles. Intact mitochondria can
be isolated from lungs by modification of standard
techniques based ontissue homogenization and differen-
tial centrifugation (1,48-50,56,57). These isolated mito-
chondria have a full complement of respiratory chain
cytochromes and demonstrate respiration that is cou-
pled to ATP synthesis (49). Morphologically, isolated
lungmitochondria resemble those isolated from liver (1)
but show considerably fewer cristae than heart mito-
chondria. Rates of substrate oxidation, degree of cou-
pling (i.e., respiratory control ratio), and content of
cytochromes with most preparations have been some-
what less than observed with liver preparations;
however, this difference may be related primarily to the
greater contamination of lung preparations with non-
mitochondrial protein and the greater trauma required
to homogenize the lung (57).
Lung mitochondria oxidize pyruvate, glycerol-3 phos-
phate, glutamate, fatty acids, and intermediates of the
tricarboxylic acid cycle (49). These activities indicate
the presence of the pyruvate dehydrogenase complex,
glutamatetransaminases, glycerol-3phosphatedehydro-
genase, enzymes for beta-oxidation for fatty acids, and
the Krebs cycle enzymes. Thus, these isolated lung
mitochondria have the usual enzymes necessary for the
organelles to carry outtheircomplex oxidative reactions.
,B-Hydroxybutyrate, a ketone body and product offatty
acid oxidation, is oxidized poorly in comparison with
other substrates by mitochondria from the rat (49,50)
but at arelatively greaterrate by mitochondria fromthe
lungs ofother species (48). Relative rates ofoxidation of
selected substrates by lung mitochondria from several
species are shown in Table 4.
Intermediary Metabolism:
Pharmacology and Toxicology
The relationship of intermediary metabolism to lung
pathophysiology has been examined in detail for only a
limited number of conditions. Studies of this sort are
particularly vulnerable to problems with interpretation
because ofcellular heterogeneity ofthe normal lung and
heterogeneity of cellular response to toxic insults.
Conditions of toxicologic interest for which some infor-
mation is available with respect to involvement of
intermediary metabolism include pulmonary uptake of
vasoactive hormones, pulmonary edema and the effects
of oxidant exposure.
Uptake of Vasoactive Amines
The lung plays an important role in vasoactive amine
homeostasis. Thus, lungs accumulate 5-hydroxytrypt-
Tble 4. Relative rates of ADP-stimulated 02 consumption with
selected substrates by isolated lung mitochondria from various
species.
Relative ratea
Rat Rabbit Sheep Pigeon
Succinate 1 1 1 1
Pyruvate 0.75 0.92 0.82 0.69
ax-Ketoglutarate 0.75 1.33 1.00 0.73
3-OH butyrate 0.13 0.88 0.55 0.46
Glycerol-3-phosphate 0.41 0.75 0.45 0.23
a Rates are relative to the rate for succinate which is assigned
a value of 1 for each species.
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amine (serotonin) by a sodium-dependent active trans-
port process (2,58,59). This amine is subsequently
metabolized to inactive products, thereby helping to
regulate its serum concentration. Norepinephrine is
handled similarly by the lung (60). Uptake of serotonin
is depressed in the presence of mitochondrial electron
transport chain inhibitors such as KCN or anoxia
(59,61). Thus, ATP generated by mitochondrial metabo-
lism appears necessary to maintain maximal rates of
serotonin uptake.
Further evidence for the link between intermediary
metabolism and serotonin uptake by the lung is indi-
cated by a 40% decrease in uptake when glucose and
other substrates are eliminated from the perfusate (61).
Thus, catabolism of protein and other endogenous
substrates is not sufficient to maintain control rates of
5-HT uptake. The requirement for substrate was fur-
ther demonstrated by perfusing lungs with 2-deoxy-
glucose which not only competes with glucose for
glycolytic enzymes but also results in depletion oftissue
ATP stores (62). Addition of a variety of metabolizable
substrates including pyruvate, palmitate, ,-hydroxy-
butyrate, and glycerol essentially reverse the inhib-
itory effect of deoxyglucose (62) indicating that inter-
mediary metabolism plays a key role in the maintenance
of normal rates of amine uptake.
Pulmonary Edema
Pulmonary edema represents a common response to a
wide range oflunginsults. Once established, pulmonary
edema could influence lung intermediary metabolism
through alteration ofsubstrate availability, interference
with end product removal, or other secondary effects.
More interesting, though, is the possible influence of
altered intermediary metabolism on the genesis oflung
edema. Maintenance ofthe alveolar space in an edema-
free condition depends in part on maintenance ofnormal
epithelial permeability. This permeability barrier may
in turn reflect cellular metabolic activity although
specific information on this point is scanty.
Several studies have indirectly suggested a link
between lung metabolism and edema. In one study,
isolatedrat lungs perfused inthe absence ofametaboliz-
able substrate in the perfusate developed gross alveolar
edema in approximately 1 hr at physiological flow rates;
addition of glucose to the medium prolonged the time
that lungs remained edema free by 50% while substitu-
tion ofa complete nutrient mediumextended the time to
edema 5-fold (63). In another study, lungs stimulated to
become edematous showed increased glycolytic activity
and reduced lung tissue ATP (64,65). In another study,
inhibition of the mitochondrial electron transport chain
by CO appeared to qualitatively increase the tendency
towards edema in the perfused lung although the ATP
concentration was decreased significantly while the
lungs remained edema free (23). These responses sug-
gest that edema formation in some circumstances may
be related to altered cellular intermediary metabolism
although moreextensive studies are obviouslyrequired.
Response to Hyperoxia and Other Oxidants
Although all tissues are susceptible to damage from
exposure to elevated oxygen tensions, the lung is
particularly vulnerable since in most clinical situations
it is exposed to the highest PO2 (66). The toxicity of
oxygen appears to derive from the generation of toxic
free radicals subsequent to metabolic reduction of
molecular oxygen (67). The ultimate elimination of
these toxic free radicals by their further reduction to
waterrequires reducingequivalents generated intracel-
lularly from intermediary metabolism.
The major intracellular reductant involved in antioxi-
dant defenses is reduced glutathione, which, once
oxidized is restored to the reduced condition with
NADPH via the glutathione reductase reaction. NADH
may play a limited role in antioxidant defense as, for
example, in the reduction of oxidized ascorbate by
semidehydroascorbate reductase (68). In addition,
NADH may contribute to the NADPH pool by a
transhydrogenation reaction involvingthe mitochondria
as described above. However, generation of NADPH
appears to be ofprimaryimportance in protection ofthe
lung tissue against hyperoxic damage.
The role of NADPH generation in antioxidant de-
fense has been demonstrated by perfusing isolated rat
lungs during exposure to oxygen at 5 atmospheres
absolute (ATA). This maneuver led to an approximate
doubling of the rate of NADPH generation via the
pentose cycle with no change in the rate of mitochon-
drial activity (69). Thus, the effect ofhyperoxia on lung
metabolism appears to be a specific stimulation of
pentose cycle activity in order to meet the increased
demand for cytoplasmic reducing equivalents. Further
evidence of the role of pentose cycle in antioxidant
defense has been obtained by finding increased glucose-
6-phosphate dehydrogenase activity (one of the rate-
limiting enzymes of the pentose cycle) in lungs from
rats exposed chronically to sublethal levels of hyper-
oxia (70).
Paraquat, an herbicide, is another agent that pro-
duces lungtoxicity as amajor clinical manifestation (71)
and exerts an effect most likely through generation of
toxic free radicals (72). The sequence ofevents appears
to be reduction of paraquat by an NADPH-dependent
microsomal reductase, followed by autooxidation of the
reducedparaquatandconsequentgenerationofsuperox-
ide anion. The isolated, perfused lung shows a 2.5- to
3-fold increase in pentose cycle activity in the presence
of saturating concentrations of paraquat (73). Since
paraquat cannot interact directly with cytoplasmic
nucleotides, the finding of increased NADPH genera-
tionindicates an increased rate ofits utilization through
the NADPH-cytochrome c reductase and glutathione
reductase reactions. Thus, unlike oxygen toxicity,INTERMEDIARY METABOLISM OF THE LUNG 157
NADPH in paraquat toxicity acts both in the genera-
tion ofthe toxic species (reduced paraquat) as well as in
protection against the subsequent metabolic products.
The pentose cycle in this situation, therefore, repre-
sents a double-edged sword, since it acts as both
activator and protector against the toxic mechanism.
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